125 related articles for article (PubMed ID: 36890670)
1. Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients.
Åström H; Wester A; Hagström H
Scand J Gastroenterol; 2023; 58(8):931-936. PubMed ID: 36890670
[No Abstract] [Full Text] [Related]
2. Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease.
Lee S; Shaheen AA; Campbell DJT; Naugler C; Jiang J; Walker RL; Quan H; Lee J
BMC Health Serv Res; 2024 Feb; 24(1):218. PubMed ID: 38365631
[TBL] [Abstract][Full Text] [Related]
3. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM.
Hayward KL; Johnson AL; Horsfall LU; Moser C; Valery PC; Powell EE
BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33568418
[TBL] [Abstract][Full Text] [Related]
4. Validity of administrative codes associated with cirrhosis in Sweden.
Bengtsson B; Askling J; Ludvigsson JF; Hagström H
Scand J Gastroenterol; 2020 Oct; 55(10):1205-1210. PubMed ID: 32960654
[TBL] [Abstract][Full Text] [Related]
5. Validity and reliability of chronic tic disorder and obsessive-compulsive disorder diagnoses in the Swedish National Patient Register.
Rück C; Larsson KJ; Lind K; Perez-Vigil A; Isomura K; Sariaslan A; Lichtenstein P; Mataix-Cols D
BMJ Open; 2015 Jun; 5(6):e007520. PubMed ID: 26100027
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.
Kositamongkol C; Charernboon T; Chaisathaphol T; Washirasaksiri C; Auesomwang C; Sitasuwan T; Charatcharoenwitthaya P; Phisalprapa P
Medicine (Baltimore); 2021 Nov; 100(44):e27640. PubMed ID: 34871234
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.
Simon TG; Roelstraete B; Hartjes K; Shah U; Khalili H; Arnell H; Ludvigsson JF
J Hepatol; 2021 Nov; 75(5):1034-1041. PubMed ID: 34224779
[TBL] [Abstract][Full Text] [Related]
8. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
9. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
10. Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care.
Bergram M; Nasr P; Iredahl F; Kechagias S; Rådholm K; Ekstedt M
Scand J Gastroenterol; 2022 Jan; 57(1):60-69. PubMed ID: 34618619
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of International Classification of Diseases Codes for Idiopathic Intracranial Hypertension in a University Health System.
Khushzad F; Kumar R; Muminovic I; Moss HE
J Neuroophthalmol; 2021 Dec; 41(4):e679-e683. PubMed ID: 34788247
[TBL] [Abstract][Full Text] [Related]
12. Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
Blomdahl J; Nasr P; Ekstedt M; Kechagias S
Metabolism; 2021 Feb; 115():154439. PubMed ID: 33246008
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.
Lee BW; Lee YH; Park CY; Rhee EJ; Lee WY; Kim NH; Choi KM; Park KG; Choi YK; Cha BS; Lee DH;
Diabetes Metab J; 2020 Jun; 44(3):382-401. PubMed ID: 32431115
[TBL] [Abstract][Full Text] [Related]
15. Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data.
Pang JX; Ross E; Borman MA; Zimmer S; Kaplan GG; Heitman SJ; Swain MG; Burak KW; Quan H; Myers RP
BMC Gastroenterol; 2015 Sep; 15():116. PubMed ID: 26362871
[TBL] [Abstract][Full Text] [Related]
16. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
17. Positive Predictive Value of
Ivey LC; Rodriguez FH; Shi H; Chong C; Chen J; Raskind-Hood CL; Downing KF; Farr SL; Book WM
J Am Heart Assoc; 2023 Aug; 12(16):e030821. PubMed ID: 37548168
[TBL] [Abstract][Full Text] [Related]
18. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
20. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.
Hayat U; Siddiqui AA; Okut H; Afroz S; Tasleem S; Haris A
Ann Hepatol; 2021; 20():100254. PubMed ID: 32920163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
